{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["2D and 3D cell cultures", "Antibody-drug conjugates (ADCs).", "Botanical dietary supplements", "Cancer chemotherapeutic agents", "Dereplication analytical methods", "Micelles", "Molecular networking", "Nanoparticles", "Plant natural products"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30633954", "DateCompleted": {"Year": "2020", "Month": "02", "Day": "26"}, "DateRevised": {"Year": "2023", "Month": "10", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "01", "Day": "08"}], "Language": ["eng"], "ELocationID": ["S0734-9750(19)30004-7", "10.1016/j.biotechadv.2019.01.004"], "Journal": {"ISSN": "1873-1899", "JournalIssue": {"Volume": "38", "PubDate": {"Year": "2020", "Season": "Jan-Feb"}}, "Title": "Biotechnology advances", "ISOAbbreviation": "Biotechnol Adv"}, "ArticleTitle": "Current status and contemporary approaches to the discovery of antitumor agents from higher plants.", "Pagination": {"StartPage": "107337", "MedlinePgn": "107337"}, "Abstract": {"AbstractText": ["Higher plant constituents have afforded clinically available anticancer drugs. These include both chemically unmodified small molecules and their synthetic derivatives currently used or those in clinical trials as antineoplastic agents, and an updated summary is provided. In addition, botanical dietary supplements, exemplified by mangosteen and noni constituents, are also covered as potential cancer chemotherapeutic agents. Approaches to metabolite purification, rapid dereplication, and biological evaluation including analytical hyphenated techniques, molecular networking, and advanced cellular and animal models are discussed. Further, enhanced and targeted drug delivery systems for phytochemicals, including micelles, nanoparticles and antibody drug conjugates (ADCs) are described herein."], "CopyrightInformation": "Copyright \u00a9 2019 Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, United States."}], "LastName": "Agarwal", "ForeName": "Garima", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, United States."}], "LastName": "Carcache", "ForeName": "Peter J Blanco", "Initials": "PJB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, United States."}], "LastName": "Addo", "ForeName": "Ermias Mekuria", "Initials": "EM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, United States. Electronic address: kinghorn.4@osu.edu."}], "LastName": "Kinghorn", "ForeName": "A Douglas", "Initials": "AD"}], "GrantList": [{"GrantID": "P01 CA125066", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "U19 CA052956", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Biotechnol Adv", "NlmUniqueID": "8403708", "ISSNLinking": "0734-9750"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunoconjugates"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Biological Products"}, {"QualifierName": [], "DescriptorName": "Drug Delivery Systems"}, {"QualifierName": [], "DescriptorName": "Immunoconjugates"}, {"QualifierName": [], "DescriptorName": "Nanoparticles"}, {"QualifierName": [], "DescriptorName": "Plants"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Abou Assi R., Darwis Y, Abdulbaqi IM, Khan AA, Vuanghao L, Laghari MH, 2017. Morinda citrifolia (noni): a comprehensive review on its industrial uses, pharmacological activities, and clinical trials. Arabian J. Chem 10, 691\u2013707."}, {"Citation": "Afsar T, Trembley JH, Salomon CE, Razak S, Khan MR, Ahmed K, 2016. Growth inhibition and apoptosis in cancer cells induced by polyphenolic compounds of Acacia hydaspica: involvement of multiple signal transduction pathways. Sci. Rep 6, 23077.", "ArticleIdList": ["PMC4791679", "26975752"]}, {"Citation": "Aisha AFA, Abdulmajid AMS, Ismail Z, Alrokayan SA, Abu-Salah KM, 2015. Development of polymeric nanoparticles of Garcinia mangostana xanthones in eudragit RL100/RS100 for anti-colon cancer drug delivery. J. Nanomater 2015, 701979."}, {"Citation": "Alexis F, Rhee J-W, Richie JP, Radovic-Moreno AF, Langer R, Farokhzad OC, 2008. New frontiers in nanotechnology for cancer treatment. Urol. Oncol.: Semin. Orig. Invest 26, 74\u201385.", "ArticleIdList": ["18190835"]}, {"Citation": "Allard P-M, Peresse T, Bisson J, Gindro K, Marcourt L, Pham VC, Roussi F, Litaudon M, Wolfender J-L, 2016. Integration of molecular networking and in-silico MS/MS fragmentation for natural products dereplication. Anal. Chem 88, 3317\u20133323.", "ArticleIdList": ["26882108"]}, {"Citation": "Allen T, 2002. Ligand-targeted therapeutics in anticancer therapy. Nat. Rev. Cancer 2, 705\u2013763.", "ArticleIdList": ["12360278"]}, {"Citation": "Amiri-Kordestani L, Blumenthal GM, Xu QC, Zhang L, Tang SW, Ha L, et al., 2014. FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer. Clin. Cancer Res 20, 4436\u20134441.", "ArticleIdList": ["24879797"]}, {"Citation": "Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, Linder T, Wawrosch C, Uhrin P, et al., 2015. Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol. Adv 33, 1582\u20131614.", "ArticleIdList": ["PMC4748402", "26281720"]}, {"Citation": "Augustin Y, Krishna S, Kumar D, Pantziarka P, 2015. The wisdom of crowds and the repurposing of artesunate as an anticancer drug. ecancer 9, ed50.", "ArticleIdList": ["PMC4631583", "26557887"]}, {"Citation": "Ba Q, Zhou N, Duan J, Chen T, Hao M, Yang X, et al., 2012. Dihydroartemisinin exerts its anticancer activity through depleting cellular iron via transferrin receptor-1. PLoS One 7, e42703.", "ArticleIdList": ["PMC3416848", "22900042"]}, {"Citation": "Bahar M, Deng Y, Fletcher JN, Kinghorn AD, 2011. Plant-derived natural products in drug discovery and development: an overview. In: Ikan R (Ed.) Selected Topics in the Chemistry of Natural Products World Scientific Publishing Co., Singapore, pp. 11\u201348."}, {"Citation": "Bailey RL, Gahche JJ, Miller PE, Thomas PR, Dwyer JT, 2013. Why US adults use dietary supplements. JAMA Intern. Med 173, 355\u2013361.", "ArticleIdList": ["23381623"]}, {"Citation": "Balunas MJ, Kinghorn AD, 2005. Drug discovery from medicinal plants. Life Sci 78, 431\u2013441.", "ArticleIdList": ["16198377"]}, {"Citation": "Bardia A, Mayer IA, Diamond JR, Moroose RL, Isakoff SJ, Starodub AN, et al., 2017. Efficacy and safety of anti-trop-2 antibody drug conjugate sacituzumab govitecan (IMMU-132) in heavily pretreated patients with metastatic triple-negative breast cancer. J. Clin. Oncol 35, 2141\u20132148.", "ArticleIdList": ["PMC5559902", "28291390"]}, {"Citation": "Benatrehina PA, Pan L, Naman CB, Li J, Kinghorn AD, 2018. Usage, biological activity, and safety of selected botanical dietary supplements consumed in the United States. J. Tradit. Complement. Med 8, 267\u2013277.", "ArticleIdList": ["PMC5934707", "29736381"]}, {"Citation": "Berghmans S, Jette C, Langenau D, Hsu K, Stewart R, Look T, Kanki JP, 2005. Making waves in cancer research: new models in the zebrafish. Biotechniques 39, 227\u2013237.", "ArticleIdList": ["16116796"]}, {"Citation": "Beutler JA, Alvarado AB, Schaufelberger DE, Andrews P, McCloud TG, 1990. Dereplication of phorbol bioactives: Lyngbya majuscula and Croton cuneatus. J. Nat. Prod 53, 867\u2013874.", "ArticleIdList": ["2128889"]}, {"Citation": "Black KC, Kirkpatrick ND, Troutman TS, Xu L, Vagner J, Gillies RJ, Barton JK, Utzinger U, Romanowski M, 2008. Gold nanorods targeted to delta opioid receptor: plasmon-resonant contrast and photothermal agents. Mol. Imaging 7, 50\u201357.", "ArticleIdList": ["18384724"]}, {"Citation": "Bohni N, Cordero-Maldonado ML, Maes J, Siverio-Mota D, Marcourt L, Munck S, et al., 2013. Integration of microfractionation, qNMR and zebrafish screening for the in vivo bioassay-guided isolation and quantitative bioactivity analysis of natural products. PLoS One 8, e64006.", "ArticleIdList": ["PMC3660303", "23700445"]}, {"Citation": "Borris RP, 1996. Natural products research: perspectives from a major pharmaceutical company. J. Ethnopharmacol 51, 29\u201338.", "ArticleIdList": ["9213624"]}, {"Citation": "Bouslimani A, Sanchez LM, Garg N, Dorrestein PC, 2014. Mass spectrometry of natural products: current, emerging and future technologies. Nat. Prod. Rep 31, 718\u2013729.", "ArticleIdList": ["PMC4161218", "24801551"]}, {"Citation": "Brancato V, Gioiella F, Imparato G, Guarnieri D, Urciuolo F, Netti PA, 2018. 3D breast cancer microtissue reveals the role of tumor microenvironment on the transport and efficacy of free-doxorubicin in vitro. Acta Biomater 75, 200\u2013212.", "ArticleIdList": ["29864516"]}, {"Citation": "Bross PF, Beitz J, Chen G, Chen XH, Duffy E, Kieffer L, et al., 2001. Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. Clin. Cancer Res 7, 1490\u20131496.", "ArticleIdList": ["11410481"]}, {"Citation": "Butler MS, 2004. The role of natural product chemistry in drug discovery. J. Nat. Prod 67, 2141\u20132153.", "ArticleIdList": ["15620274"]}, {"Citation": "Butler MS, Robertson AA, Cooper MA, 2014. Natural product and natural product derived drugs in clinical trials. Nat. Prod. Rep 31, 1612\u20131661.", "ArticleIdList": ["25204227"]}, {"Citation": "Cardillo TM, Govindan SV, Sharkey RM, Trisal P, Goldenberg DM, 2011. Humanized anti-trop-2 IgG-SN-38 conjugate for effective treatment of diverse epithelial cancers: preclinical studies in human cancer xenograft models and monkeys. Clin. Cancer Res 17, 3157\u20133169.", "ArticleIdList": ["PMC10766325", "21372224"]}, {"Citation": "Cardillo TM, Govindan SV, Sharkey RM, Trisal P, Arrojo R, Liu D, Rossi EA, Chang CH, Goldenberg DM, 2015. Sacituzumab govitecan (IMMU-132), an anti-trop-2/SN-38 antibody-drug conjugate: characterization and efficacy in pancreatic, gastric, and other cancers. Bioconjug. Chem 26, 919\u2013931.", "ArticleIdList": ["25915780"]}, {"Citation": "Carter LG, D\u2019Orazio JA, Pearson KJ, 2014. Resveratrol and cancer: focus on in vivo evidence. Endocr. Relat. Cancer 21, 209\u2013225.", "ArticleIdList": ["PMC4013237", "24500760"]}, {"Citation": "Carugo D, Bottaro E, Owen J, Stride E, Nastruzzi C, 2016. Liposome production by microfluidics: potential and limiting factors. Sci. Rep 6, 25876.", "ArticleIdList": ["PMC4872163", "27194474"]}, {"Citation": "Casciari JJ, Hollingshead MG, Alley MC, Mayo JG, Malspeis L, Miyauchi S, Grever MR, Weinstein JN, 1994. Growth and chemotherapeutic response of cells in a hollow-fiber in vitro solid tumor. J. Natl. Cancer Inst 86, 1846\u20131852.", "ArticleIdList": ["7990159"]}, {"Citation": "Cassady JM, Chan KK, Floss HG, Leistner E, 2004. Recent developments in the maytansinoid antitumor agents. Chem. Pharm. Bull 52, 1\u201326.", "ArticleIdList": ["14709862"]}, {"Citation": "Cekanova M, Rathore K, 2014. Animal models and therapeutic molecular targets of cancer: utility and limitations. Drug Des. Devel. Ther 8, 1911\u20131921.", "ArticleIdList": ["PMC4206199", "25342884"]}, {"Citation": "Cencic R, Carrier M, Galicia-Vazquez G, Bordeleau ME, Sukarieh R, Bourdeau A, et al., 2009. Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol. PLoS One 4, e5223.", "ArticleIdList": ["PMC2671147", "19401772"]}, {"Citation": "Chan-Blanco Y, Vaillant F, Mercedes Perez A., Reynes M, Brillouet J-M, Brat P, 2006. The noni fruit (Morinda citrifolia L.): a review of agricultural research, nutritional and therapeutic properties. J. Food Compost. Anal 19, 645\u2013654."}, {"Citation": "Chang HF, Wu CH, Yang LL, 2013. Antitumour and free radical scavenging effects of \u03b3-mangostin isolated from Garcinia mangostana pericarps against hepatocellular carcinoma cell. J. Pharm. Pharmacol 65, 1419\u20131428.", "ArticleIdList": ["23927480"]}, {"Citation": "Chari RV, 1998. Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy. Adv. Drug Deliv. Rev 31, 89\u2013104.", "ArticleIdList": ["10837619"]}, {"Citation": "Chari RV, 2008. Targeted cancer therapy: conferring specificity to cytotoxic drugs. Acc. Chem. Res 41, 98\u2013107.", "ArticleIdList": ["17705444"]}, {"Citation": "Chari RV, Miller ML, Widdison WC, 2014. Antibody-drug conjugates: an emerging concept in cancer therapy. Angew. Chem. Int. Ed. Engl 53, 3796\u20133827.", "ArticleIdList": ["24677743"]}, {"Citation": "Chari RV, 2016. Expanding the reach of antibody-drug conjugates. ACS Med. Chem. Lett 7, 974\u2013976.", "ArticleIdList": ["PMC5108034", "27882193"]}, {"Citation": "Chervin J, Perio P, Martins-Froment N, Pharkeovilay C, Reybier K, Nepveu F, et al., 2017. Dereplication of natural products from complex extracts by regression analysis and molecular networking: case study of redox-active compounds from Viola alba subsp. dehnhardtii. Metabolomics 13, 96."}, {"Citation": "Chin YW, Balunas MJ, Chai H, Kinghorn AD, 2006. Drug discovery from natural sources. AAPS J 8, E239\u2013E253.", "ArticleIdList": ["PMC3231566", "16796374"]}, {"Citation": "Chin YW, Kinghorn AD, 2008. Structural characterization, biological effects, and synthetic studies on xanthones from mangosteen (Garcinia mangostana), a popular botanical dietary supplement. Mini Rev. Org. Chem 5, 355\u2013364.", "ArticleIdList": ["PMC3090081", "21562610"]}, {"Citation": "Chitchumroonchokchai C, Thomas-Ahner JM, Li J, Riedl KM, Nontakham J, Suksumrarn S, Clinton SK, Kinghorn AD, Failla ML, 2013. Anti-tumorigenicity of dietary \u03b1-mangostin in an HT-29 colon cell xenograft model and the tissue distribution of xanthones and their phase II metabolites. Mol. Nutr. Food Res 57, 203\u2013211.", "ArticleIdList": ["PMC3886125", "23239542"]}, {"Citation": "Cho K, Wang X, Nie S, Chen Z, Shin DM, 2008. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res 14, 1310.", "ArticleIdList": ["18316549"]}, {"Citation": "Clarke WT, Marks PW, 2010. Gemtuzumab ozogamicin: is there room for salvage? Blood 116, 2618\u20132619.", "ArticleIdList": ["20930085"]}, {"Citation": "Clarkson C, Staerk D, Hansen SH, Smith PJ, Jaroszewski JW, 2006. Identification of major and minor constituents of Harpagophytum procumbens (Devil\u2019s Claw) using HPLC-SPE-NMR and HPLC-ESIMS/APCIMS. J. Nat. Prod 69, 1280\u20131288.", "ArticleIdList": ["16989520"]}, {"Citation": "Corcoran O, Spraul M, 2003. LC-NMR-MS in drug discovery. Drug Discov. Today 8, 624\u2013631.", "ArticleIdList": ["12867148"]}, {"Citation": "Cragg GM, Newman DJ, 2000. Antineoplastic agents from natural sources: achievements and future directions. Expert Opin. Investig. Drugs 9, 2783\u20132797.", "ArticleIdList": ["11093353"]}, {"Citation": "Cragg GM, Newman DJ, 2001a. Medicinals for the millennia: the historical record. Ann. N. Y. Acad. Sci 953, 3\u201325.", "ArticleIdList": ["11795420"]}, {"Citation": "Cragg GM, Newman DJ, 2001b. Natural product drug discovery in the next millennium. Pharm. Biol 39, 8\u201317.", "ArticleIdList": ["21554167"]}, {"Citation": "Cragg GM, Newman DJ, 2003. Plants as a source of anti\u2010cancer and anti\u2010HIV agents. Ann. Appl. Biol 143, 127\u2013133."}, {"Citation": "Cragg GM, Newman DJ, 2004. A tale of two tumor targets: topoisomerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy. J. Nat. Prod 67, 232\u2013244.", "ArticleIdList": ["14987065"]}, {"Citation": "Cragg GM, Newman DJ, 2005. Plants as a source of anti-cancer agents. J. Ethnopharmacol 100, 72\u201379.", "ArticleIdList": ["16009521"]}, {"Citation": "Cragg GM, Grothaus PG, Newman DJ, 2009. Impact of natural products on developing new anti-cancer agents. Chem. Rev 109, 3012\u20133043.", "ArticleIdList": ["19422222"]}, {"Citation": "Cragg GM, Newman DJ, 2013. Natural products: a continuing source of novel drug leads. Biochim. Biophys. Acta 1830, 3670\u20133695.", "ArticleIdList": ["PMC3672862", "23428572"]}, {"Citation": "Cragg GM, Grothaus PG, Newman DJ, 2014. New horizons for old drugs and drug leads. J. Nat. Prod 77, 703\u2013723.", "ArticleIdList": ["24499205"]}, {"Citation": "Cragg GM, Pezzuto JM, 2016. Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents. Med. Princ. Pract 25, 41\u201359.", "ArticleIdList": ["PMC5588531", "26679767"]}, {"Citation": "Crusemann M, O\u2019Neill EC, Larson CB, Melnik AV, Floros DJ, da Silva RR, Jensen PR, Dorrestein PC, Moore BS, 2017. Prioritizing natural product diversity in a collection of 146 bacterial strains based on growth and extraction protocols. J. Nat. Prod 80, 588\u2013597.", "ArticleIdList": ["PMC5367486", "28335604"]}, {"Citation": "Cuenca AG, Jiang H, Hochwald SN, Delano M, Cance WG, Grobmyer SR, 2006. Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer 107, 459\u2013466.", "ArticleIdList": ["16795065"]}, {"Citation": "Cui H, Li TL, Guo HF, Wang JL, Xue P, Zhang Y, Fan JH, Li ZP, Gao YJ, 2018. Silymarin-mediated regulation of the cell cycle and DNA damage response exerts antitumor activity in human hepatocellular carcinoma. Oncol. Lett 15, 885\u2013892.", "ArticleIdList": ["PMC5772825", "29399153"]}, {"Citation": "David B, Wolfender J-L, Dias DA, 2015. The pharmaceutical industry and natural products: historical status and new trends. Phytochem. Rev 14, 299\u2013315."}, {"Citation": "de Claro RA, McGinn K, Kwitkowski V, Bullock J, Khandelwal A, Habtemariam B, et al., 2012. U.S. Food and Drug Administration approval summary: brentuximab vedotin for the treatment of relapsed Hodgkin lymphoma or relapsed systemic anaplastic large-cell lymphoma. Clin. Cancer Res 18, 5845\u20135849.", "ArticleIdList": ["22962441"]}, {"Citation": "de Goeij BE, Lambert JM, 2016. New developments for antibody-drug conjugate-based therapeutic approaches. Curr. Opin. Immunol 40, 14\u201323.", "ArticleIdList": ["26963132"]}, {"Citation": "De Jong WH, Borm PJA, 2008. Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomed 3, 133\u2013149.", "ArticleIdList": ["PMC2527668", "18686775"]}, {"Citation": "de Oliveira GG, Carnevale Neto F., Demarque DP, de Sousa Pereira-Junior JA, Sampaio Peixoto Filho R.C., de Melo SJ, da Silva Almeida JRG, Lopes JLC, Lopes NP, 2017. Dereplication of flavonoid glycoconjugates from Adenocalymma imperatoris-maximilianii by untargeted tandem mass spectrometry-based molecular networking. Planta Med 83, 636\u2013646.", "ArticleIdList": ["27806406"]}, {"Citation": "DiJoseph JF, Armellino DC, Boghaert ER, Khandke K, Dougher MM, Sridharan L, et al., 2004. Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies. Blood 103, 1807\u20131814.", "ArticleIdList": ["14615373"]}, {"Citation": "Doi T, Shitara K, Naito Y, Shimomura A, Fujiwara Y, Yonemori K, et al., 2017. Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study. Lancet Oncol 18, 1512\u20131522.", "ArticleIdList": ["29037983"]}, {"Citation": "Doronina SO, Toki BE, Torgov MY, Mendelsohn BA, Cerveny CG, Chace DF, et al., 2003. Development of potent monoclonal antibody auristatin conjugates for cancer therapy. Nat. Biotechnol 21, 778\u2013784.", "ArticleIdList": ["12778055"]}, {"Citation": "Dotan E, Cohen SJ, Starodub AN, Lieu CH, Messersmith WA, Simpson PS, et al., 2017. Phase I/II trial of labetuzumab govitecan (anti-CEACAM5/SN-38 antibody-drug conjugate) in patients with refractory or relapsing metastatic colorectal cancer. J. Clin. Oncol 35, 3338\u20133346.", "ArticleIdList": ["PMC8259133", "28817371"]}, {"Citation": "Drobnik J, Drobnik E, 2016. Timeline and bibliography of early isolations of plant metabolites (1770\u20131820) and their impact to pharmacy: a critical study. Fitoterapia 115, 155\u2013164.", "ArticleIdList": ["27984164"]}, {"Citation": "Ducry L, Stump B, 2010. Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies. Bioconjug. Chem 21, 5\u201313.", "ArticleIdList": ["19769391"]}, {"Citation": "Duncan KR, Crusemann M, Lechner A, Sarkar A, Li J, Ziemert N, et al., 2015. Molecular networking and pattern-based genome mining improves discovery of biosynthetic gene clusters and their products from Salinispora species. Chem. Biol 22, 460\u2013471.", "ArticleIdList": ["PMC4409930", "25865308"]}, {"Citation": "Ebada SS, Lajkiewicz N, Porco JA Jr., Li-Weber M, Proksch P, 2011. Chemistry and biology of rocaglamides (= flavaglines) and related derivatives from Aglaia species (Meliaceae). In: Kinghorn AD, Falk H, Kobayashi J (Eds.), Progress in the Chemistry of Organic Natural Products Springer-Verlag, Vienna, pp. 1\u201358.", "ArticleIdList": ["PMC4157394", "21833837"]}, {"Citation": "Esposito M, Nothias L-F, Retailleau P, Costa J, Roussi F, Neyts J, et al., 2017. Isolation of premyrsinane, myrsinane, and tigliane diterpenoids from Euphorbia pithyusa using a chikungunya virus cell-based assay and analogue annotation by molecular networking. J. Nat. Prod 80, 2051\u20132059.", "ArticleIdList": ["28671832"]}, {"Citation": "Exarchou V, Krucker M, van Beek TA, Vervoort J, Gerothanassis IP, Albert K, 2005. LC-NMR coupling technology: recent advancements and applications in natural products analysis. Magn. Reson. Chem 43, 681\u2013687.", "ArticleIdList": ["16049952"]}, {"Citation": "Faltas B, Goldenberg DM, Ocean AJ, Govindan SV, Wilhelm F, Sharkey RM, et al., 2016. Sacituzumab govitecan, a novel antibody-drug conjugate, in patients with metastatic platinum-resistant urothelial carcinoma. Clin. Genitourin. Cancer 14, e75\u2013e79.", "ArticleIdList": ["26541586"]}, {"Citation": "Fang Y, Eglen RM, 2017. Three-dimensional cell cultures in drug discovery and development. SLAS Discov 22, 456\u2013472.", "ArticleIdList": ["PMC5448717", "28520521"]}, {"Citation": "Fischer J, Ganellin CR, Ganesan A, Proudfoot J, 2010. Standalone drugs. In: Fischer J, Ganellin CR (Eds.), Analogue-based Drug Discovery II Wiley-VCH, Weinheim, pp. 29\u201360."}, {"Citation": "Fox Ramos AE, Alcover C, Evanno L, Maciuk A, Litaudon M, Duplais C, et al., 2017. Revisiting previously investigated plants: a molecular networking-based study of Geissospermum laeve. J. Nat. Prod 80, 1007\u20131014.", "ArticleIdList": ["28282127"]}, {"Citation": "Garg N, Kapono C, Lim YW, Koyama N, Vermeij MJ, Conrad D, Rohwer F, Dorrestein PC, 2015. Mass spectral similarity for untargeted metabolomics data analysis of complex mixtures. Int. J. Mass Spectrom 377, 719\u2013727.", "ArticleIdList": ["PMC4379709", "25844058"]}, {"Citation": "Gaudencio SP, Pereira F, 2015. Dereplication: racing to speed up the natural products discovery process. Nat. Prod. Rep 32, 779\u2013810.", "ArticleIdList": ["25850681"]}, {"Citation": "Gerber HP, Koehn FE, Abraham RT, 2013. The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics. Nat. Prod. Rep 30, 625\u2013639.", "ArticleIdList": ["23525375"]}, {"Citation": "Gertsch J, 2009. How scientific is the science in ethnopharmacology? Historical perspectives and epistemological problems. J. Ethnopharmacol 122, 177\u2013183.", "ArticleIdList": ["19185054"]}, {"Citation": "Goldenberg DM, Cardillo TM, Govindan SV, Rossi EA, Sharkey RM, 2015. Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC). Oncotarget 6, 22496\u201322512.", "ArticleIdList": ["PMC4673178", "26101915"]}, {"Citation": "Gomes NGM, Pereira DM, Valentao P, Andrade PB, 2018. Hybrid MS/NMR methods on the prioritization of natural products: applications in drug discovery. J. Pharm. Biomed. Anal 147, 234\u2013249.", "ArticleIdList": ["28826951"]}, {"Citation": "Gonzalez-Vallinas M, Gonzalez-Castejon M, Rodriguez-Casado A, Ramirez de Molina A, 2013. Dietary phytochemicals in cancer prevention and therapy: a complementary approach with promising perspectives. Nutr. Rev 71, 585\u2013599.", "ArticleIdList": ["24032363"]}, {"Citation": "Govindan SV, Cardillo TM, Rossi EA, Trisal P, McBride WJ, Sharkey RM, Goldenberg DM, 2015. Improving the therapeutic index in cancer therapy by using antibody-drug conjugates designed with a moderately cytotoxic drug. Mol. Pharm 12, 1836\u20131847.", "ArticleIdList": ["25402018"]}, {"Citation": "Gray JE, Heist RS, Starodub AN, Camidge DR, Kio EA, Masters GA, et al., 2017. Therapy of small cell lung cancer (SCLC) with a topoisomerase-I-inhibiting antibody-drug conjugate (ADC) targeting trop-2, sacituzumab govitecan. Clin. Cancer Res 23, 5711\u20135719.", "ArticleIdList": ["28679770"]}, {"Citation": "Grobmyer SR, Iwakuma N, Sharma P, Moudgil BM, 2010. What is cancer nanotechnology? In: Grobmyer SR, Moudgil BM (Eds.), Cancer Nanotechnology, Methods and Protocols Humana Press, New York, pp. 1\u201310."}, {"Citation": "Grossman SA, Ye X, Peereboom D, Rosenfeld MR, Mikkelsen T, Supko JG, Desideri S, 2012. Phase I study of terameprocol in patients with recurrent high-grade glioma. Neuro Oncol 14, 511\u2013517.", "ArticleIdList": ["PMC3309850", "22323663"]}, {"Citation": "Gupta SC, Sung B, Prasad S, Webb LJ, Aggarwal BB, 2013. Cancer drug discovery by repurposing: teaching new tricks to old dogs. Trends Pharmacol. Sci 34, 508\u2013517.", "ArticleIdList": ["23928289"]}, {"Citation": "Gutierrez-Orozco F, Failla ML, 2013. Biological activities and bioavailability of mangosteen xanthones: a critical review of the current evidence. Nutrients 5, 3163\u20133183.", "ArticleIdList": ["PMC3775248", "23945675"]}, {"Citation": "Hafeez BB, Mustafa A, Fischer JW, Singh A, Zhong W, Shekhani MO, et al., 2014. \u03b1-Mangostin: a dietary antioxidant derived from the pericarp of Garcinia mangostana L. inhibits pancreatic tumor growth in xenograft mouse model. Antioxid. Redox Signaling 21, 682\u2013699.", "ArticleIdList": ["PMC4104617", "24295217"]}, {"Citation": "Halfter K, Hoffmann O, Ditsch N, Ahne M, Arnold F, Paepke S, Grab D, Bauerfeind I, Mayer B, 2016. Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids. J. Transl. Med 14, 112.", "ArticleIdList": ["PMC4855689", "27142386"]}, {"Citation": "Hamann PR, Hinman LM, Hollander I, Beyer CF, Lindh D, Holcomb R, et al., 2002. Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Bioconjug. Chem 13, 47\u201358.", "ArticleIdList": ["11792178"]}, {"Citation": "Hamel E, 1992. Natural products which interact with tubulin in the vinca domain: maytansine, rhizoxin, phomopsin A, dolastatins 10 and 15 and halichondrin B. Pharmacol. Ther 55, 31\u201351.", "ArticleIdList": ["1287674"]}, {"Citation": "Han A-R, Kim J-A, Lantvit DD, Kardono BS, Riswan S, Chai H-B, et al., 2009. Cytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen). J. Nat. Prod 72, 2028\u20132031.", "ArticleIdList": ["PMC2887388", "19839614"]}, {"Citation": "Hanka LJ, Kuentzel SL, Martin DG, Wiley PF, Neil GL, 1978. Detection and assay of antitumor antibiotics. Recent Results Cancer Res 63, 69\u201376.", "ArticleIdList": ["705015"]}, {"Citation": "Haque MU, Ferdiousi N, Sajon SR, 2016. Anti-cancer agents derived from plant and dietary sources: a review. Int. J. Pharmacogn 3, 55\u201366."}, {"Citation": "Hartmann AC, Petras D, Quinn RA, Protsyuk I, Archer FI, Ransome E, et al., 2017. Meta-mass shift chemical profiling of metabolomes from coral reefs. Proc. Natl. Acad. Sci. U.S.A 114, 11685\u201311690.", "ArticleIdList": ["PMC5676912", "29078340"]}, {"Citation": "He X, Esteva FJ, Ensor J, Hortobagyi GN, Lee MH, Yeung SC, 2012. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer. Ann. Oncol 23, 1771\u20131780.", "ArticleIdList": ["PMC3387820", "22112968"]}, {"Citation": "Heath JR, Davis ME, 2008. Nanotechnology and cancer. Annu. Rev. Med 59, 251\u2013265.", "ArticleIdList": ["PMC3706454", "17937588"]}, {"Citation": "Heist RS, Guarino MJ, Masters G, Purcell WT, Starodub AN, Horn L, et al., 2017. Therapy of advanced non-small-cell lung cancer with an SN-38-anti-trop-2 drug conjugate, sacituzumab govitecan. J. Clin. Oncol 35, 2790\u20132797.", "ArticleIdList": ["28548889"]}, {"Citation": "Henkin JM, Ren Y, Soejarto DD, Kinghorn AD, 2018. The search for anticancer agents from topical plants. In: Kinghorn AD, Falk H, Gibbons S, Kobayashi J, Asakawa Y, Liu J-K (Eds.), Progress in the Chemistry of Organic Natural Products Springer-International, Cham, Switzerland, pp. 1\u201394.", "ArticleIdList": ["30178270"]}, {"Citation": "Hirschfeld T, 1980. The hy-phen-ated methods. Anal. Chem 52, 297A\u2013312A."}, {"Citation": "Ho C-K, Huang Y-L, Chen C-C, 2002. Garcinone E, a xanthone derivative, has potent cytotoxic effect against hepatocellular carcinoma cell lines. Planta Med 68, 975\u2013979.", "ArticleIdList": ["12451486"]}, {"Citation": "Hollingshead MG, Alley MC, Camalier RF, Abbott BJ, Mayo JG, Malspeis L, Grever MR, 1995. In vivo cultivation of tumor cells in hollow fibers. Life Sci 57, 131\u2013141.", "ArticleIdList": ["7603295"]}, {"Citation": "Hood E, 2004. Nanotechnology: looking as we leap. Environ. Health Perspect 112, A740\u2013749.", "ArticleIdList": ["PMC1247535", "15345364"]}, {"Citation": "Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M, et al., 2013. The zebrafish reference genome sequence and its relationship to the human genome. Nature 496, 498\u2013503.", "ArticleIdList": ["PMC3703927", "23594743"]}, {"Citation": "Hubbard JM, Grothey A, 2017. Napabucasin: an update on the first-in-class cancer stemness inhibitor. Drugs 77, 1091\u20131103.", "ArticleIdList": ["28573435"]}, {"Citation": "Hubert J, Nuzillard J-M, Renault J-H, 2017. Dereplication strategies in natural product research: how many tools and methodologies behind the same concept? Phytochem. Rev 16, 55\u201395."}, {"Citation": "Hwang BY, Su BN, Chai H-B, Mi Q, Kardono BS, Afriastini JJ, et al., 2004. Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris. J. Org. Chem 69, 3350\u20133358; ibid, 69, 6156.", "ArticleIdList": ["15132542"]}, {"Citation": "Imamura Y, Mukohara T, Shimono Y, Funakoshi Y, Chayahara N, Toyoda M, et al., 2015. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer. Oncol. Rep 33, 1837\u20131843.", "ArticleIdList": ["25634491"]}, {"Citation": "Ito T, Masubuchi M, 2014. Dereplication of microbial extracts and related analytical technologies. J. Antibiot 67, 353\u2013360.", "ArticleIdList": ["24569671"]}, {"Citation": "Itokawa H, Hitotsuyanagi Y, Lee K-H, 2012. Homoharringtonine and related compounds. In: Cragg GM, Kingston DG, Newman DJ (Eds.), Anticancer Agents from Natural Products CRC Press, Boca Raton, Florida, pp. 65\u201394."}, {"Citation": "Iyer U, Kadambi VJ, 2011. Antibody drug conjugates-trojan horses in the war on cancer. J. Pharmacol. Toxicol. Methods 64, 207\u2013212.", "ArticleIdList": ["21843648"]}, {"Citation": "Jabr-Milane LS, van Vlerken LE, Yadav S, Amiji MM, 2008. Multi-functional nanocarriers to overcome tumor drug resistance. Cancer Treat. Rev 34, 592\u2013602.", "ArticleIdList": ["PMC2585991", "18538481"]}, {"Citation": "Jaroszewski JW, 2005a. Hyphenated NMR methods in natural products research, Part 1: Direct hyphenation. Planta Med 71, 691\u2013700.", "ArticleIdList": ["16142630"]}, {"Citation": "Jaroszewski JW, 2005b. Hyphenated NMR methods in natural products research, Part 2: HPLC-SPE-NMR and other new trends in NMR hyphenation. Planta Med 71, 795\u2013802.", "ArticleIdList": ["16206031"]}, {"Citation": "Jia QI, 2003. Generating and screening a natural product library for cyclooxygenase and lipoxygenase dual inhibitors. In: Atta-ur-Rahman (Ed.) Studies in Natural Products Chemistry Elsevier B.V., Amsterdam, pp. 643\u2013718."}, {"Citation": "Johansen KT, Wubshet SG, Nyberg NT, Jaroszewski JW, 2011. From retrospective assessment to prospective decisions in natural product isolation: HPLC-SPE-NMR analysis of Carthamus oxyacantha. J. Nat. Prod 74, 2454\u20132461.", "ArticleIdList": ["22060189"]}, {"Citation": "Johansen KT, Wubshet SG, Nyberg NT, 2013. HPLC-NMR revisited: using time-slice high-performance liquid chromatography-solid-phase extraction-nuclear magnetic resonance with database-assisted dereplication. Anal. Chem 85, 3183\u20133189.", "ArticleIdList": ["23432092"]}, {"Citation": "Johnson JJ, Petiwala SM, Syed DN, Rasmussen JT, Adhami VM, Siddiqui IA, Kohl AM, Mukhtar H, 2012. \u03b1-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth. Carcinogenesis 33, 413\u2013419.", "ArticleIdList": ["PMC3271271", "22159229"]}, {"Citation": "Jordan MA, Wilson L, 2004. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 4, 253\u2013265.", "ArticleIdList": ["15057285"]}, {"Citation": "Jorgenson JW, 2010. Capillary liquid chromatography at ultrahigh pressures. Annu. Rev. Anal. Chem 3, 129\u2013150.", "ArticleIdList": ["20636037"]}, {"Citation": "Jung C, Hong JY, Bae SY, Kang SS, Park HJ, Lee SK, 2015. Antitumor activity of americanin A isolated from the seeds of Phytolacca americana by regulating the ATM/ATR signaling pathway and the skp2-p27 axis in human colon cancer cells. J. Nat. Prod 78, 2983\u20132993.", "ArticleIdList": ["26595875"]}, {"Citation": "Jung H-A, Su B-N, Keller WJ, Mehta RG, Kinghorn AD, 2006. Antioxidant xanthones from the pericarp of Garcinia mangostana (mangosteen). J. Agric. Food Chem 54, 2077\u20132082.", "ArticleIdList": ["16536578"]}, {"Citation": "Kabanov AV, Batrakova EV, Alakhov VY, 2002. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J. Control. Release 82, 189\u2013212.", "ArticleIdList": ["12175737"]}, {"Citation": "Kantarjian HM, DeAngelo DJ, Stelljes M, Martinelli G, Liedtke M, Stock W, et al., 2016. Inotuzumab ozogamicin versus standard therapy for acute lymphoblastic leukemia. N. Engl. J. Med 375, 740\u2013753.", "ArticleIdList": ["PMC5594743", "27292104"]}, {"Citation": "Kapa\u0142czy\u0144ska M, Kolenda T, Przyby\u0142a W, Zaj\u0105czkowska M, Teresiak A, Filas V, et al., 2018. 2D and 3D cell cultures \u2013 a comparison of different types of cancer cell cultures. Arch. Med. Sci 14, 910\u2013919.", "ArticleIdList": ["PMC6040128", "30002710"]}, {"Citation": "Katz L, Baltz RH, 2016. Natural product discovery: past, present, and future. J. Ind. Microbiol. Biotechnol 43, 155\u2013176.", "ArticleIdList": ["26739136"]}, {"Citation": "Kesting JR, Olsen L, Staerk D, Tejesvi MV, Kini KR, Prakash HS, Jaroszewski JW, 2011. Production of unusual dispiro metabolites in Pestalotiopsis virgatula endophyte cultures: HPLC-SPE-NMR, electronic circular dichroism, and time-dependent density-functional computation study. J. Nat. Prod 74, 2206\u20132215.", "ArticleIdList": ["21942847"]}, {"Citation": "Khazir J, Mir BA, Pilcher L, Riley DL, 2014. Role of plants in anticancer drug discovery. Phytochem. Lett 7, 173\u2013181."}, {"Citation": "Khonkarn R, Mankhetkorn S, Talelli M, Hennink WE, Okonogi S, 2012. Cytostatic effect of xanthone-loaded mPEG-b-p(HPMAm-Lac2) micelles towards doxorubicin sensitive and resistant cancer cells. Colloids Surf. B 94, 266\u2013273.", "ArticleIdList": ["22377215"]}, {"Citation": "Kinghorn AD, Chin YW, Swanson SM, 2009. Discovery of natural product anticancer agents from biodiverse organisms. Curr. Opin. Drug Discov. Devel 12, 189\u2013196.", "ArticleIdList": ["PMC2877274", "19333864"]}, {"Citation": "Kinghorn AD, Chai HB, Sung CK, Keller WJ, 2011a. The classical drug discovery approach to defining bioactive constituents of botanicals. Fitoterapia 82, 71\u201379.", "ArticleIdList": ["20804827"]}, {"Citation": "Kinghorn AD, Pan L, Fletcher JN, Chai H, 2011b. The relevance of higher plants in lead compound discovery programs. J. Nat. Prod 74, 1539\u20131555.", "ArticleIdList": ["PMC3158731", "21650152"]}, {"Citation": "Kinghorn AD, Carcache de Blanco E.J., Lucas DM, Rakotondraibe HL, Orjala J, Soejarto DD, et al., 2016. Discovery of anticancer agents of diverse natural origin. Anticancer Res 36, 5623\u20135637.", "ArticleIdList": ["PMC5098703", "27793884"]}, {"Citation": "Kingston DG, 2011. Modern natural products drug discovery and its relevance to biodiversity conservation. J. Nat. Prod 74, 496\u2013511.", "ArticleIdList": ["PMC3061248", "21138324"]}, {"Citation": "Kirpotin DB, Drummond DC, Shao Y, Shalaby MR, Hong K, Nielsen UB, Marks JD, Benz CC, Park JW, 2006. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res 66, 6732\u20136740.", "ArticleIdList": ["16818648"]}, {"Citation": "Kleigrewe K, Almaliti J, Tian IY, Kinnel RB, Korobeynikov A, Monroe EA, et al., 2015. Combining mass spectrometric metabolic profiling with genomic analysis: a powerful approach for discovering natural products from cyanobacteria. J. Nat. Prod 78, 1671\u20131682.", "ArticleIdList": ["PMC4681511", "26149623"]}, {"Citation": "Klein-Junior LC, Cretton S, Allard PM, Genta-Jouve G, Passos CS, Salton J, et al., 2017. Targeted isolation of monoterpene indole alkaloids from Palicourea sessilis. J. Nat. Prod 80, 3032\u20133037.", "ArticleIdList": ["29120642"]}, {"Citation": "Ko AH, LoConte N, Tempero MA, Walker EJ, Kate Kelley R., Lewis S, et al., 2016. A phase I study of FOLFIRINOX plus IPI-926, a hedgehog pathway inhibitor, for advanced pancreatic adenocarcinoma. Pancreas 45, 370\u2013375.", "ArticleIdList": ["PMC5908466", "26390428"]}, {"Citation": "Kong G, Braun RD, Dewhirst MW, 2000. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res 60, 4440\u20134445.", "ArticleIdList": ["10969790"]}, {"Citation": "Kongstad KT, Wubshet SG, Johannesen A, Kjellerup L, Winther AM, Jager AK, Staerk D, 2014. High-resolution screening combined with HPLC-HRMS-SPE-NMR for identification of fungal plasma membrane H+-ATPase inhibitors from plants. J. Agric. Food Chem 62, 5595\u20135602.", "ArticleIdList": ["24830509"]}, {"Citation": "Kordes S, Pollak MN, Zwinderman AH, Math\u00f4t RA, Weterman MJ, Beeker A, Punt CJ, Richel DJ, Wilmink JW, 2015. Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial. Lancet Oncol 16, 839\u2013847.", "ArticleIdList": ["26067687"]}, {"Citation": "Korfmacher WA, 2005. Principles and applications of LC-MS in new drug discovery. Drug Discov. Today 10, 1357\u20131367.", "ArticleIdList": ["16253874"]}, {"Citation": "Kotecha R, Takami A, Espinoza JL, 2016. Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence. Oncotarget 7, 52517\u201352529.", "ArticleIdList": ["PMC5239570", "27232756"]}, {"Citation": "Kuligowski J, Quint\u00e1s G, Garrigues S, Lendl B, de la Guardia M, 2010. Recent advances in on-line liquid chromatography - infrared spectrometry (LC-IR). Trends Anal. Chem 29, 544\u2013552."}, {"Citation": "Kupchan SM, Komoda Y, Court WA, Thomas GJ, Smith RM, Karim A, Gilmore CJ, Haltiwanger RC, Bryan RF, 1972. Tumor inhibitors. LXXIII. Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus. J. Am. Chem. Soc 94, 1354\u20131356.", "ArticleIdList": ["5062169"]}, {"Citation": "Kurita KL, Linington RG, 2015. Connecting phenotype and chemotype: high-content discovery strategies for natural products research. J. Nat. Prod 78, 587\u2013596.", "ArticleIdList": ["PMC7505086", "25728167"]}, {"Citation": "Kusari S, Lamshoft M, Kusari P, Gottfried S, Zuhlke S, Louven K, Hentschel U, Kayser O, Spiteller M, 2014. Endophytes are hidden producers of maytansine in Putterlickia roots. J. Nat. Prod 77, 2577\u20132584.", "ArticleIdList": ["25478947"]}, {"Citation": "Kwon GS, Okano T, 1999. Soluble self-assembled block copolymers for drug delivery. Pharm. Res 16, 597\u2013600.", "ArticleIdList": ["10349998"]}, {"Citation": "Lam KS, 2007. New aspects of natural products in drug discovery. Trends Microbiol 15, 279\u2013289.", "ArticleIdList": ["17433686"]}, {"Citation": "Lambert JM, 2005. Drug-conjugated monoclonal antibodies for the treatment of cancer. Curr. Opin. Pharmacol 5, 543\u2013549.", "ArticleIdList": ["16087399"]}, {"Citation": "Lambert JM, Chari RV, 2014. Ado-trastuzumab emtansine (T-DM1): an antibody-drug conjugate (ADC) for HER2-positive breast cancer. J. Med. Chem 57, 6949\u20136964.", "ArticleIdList": ["24967516"]}, {"Citation": "Lambert JM, Morris CQ, 2017. Antibody-drug conjugates (ADCs) for personalized treatment of solid tumors: a review. Adv. Ther 34, 1015\u20131035.", "ArticleIdList": ["PMC5427099", "28361465"]}, {"Citation": "Lammers T, Hennink WE, Storm G, 2008. Tumour-targeted nanomedicines: principles and practice. Br. J. Cancer 99, 392\u2013397.", "ArticleIdList": ["PMC2527811", "18648371"]}, {"Citation": "Leal M, Sapra P, Hurvitz SA, Senter P, Wahl A, Schutten M, Shah DK, Haddish-Berhane N, Kabbarah O, 2014. Antibody-drug conjugates: an emerging modality for the treatment of cancer. Ann. N.Y. Acad. Sci 1321, 41\u201354.", "ArticleIdList": ["25123209"]}, {"Citation": "Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, Berman B, 2012. Ingenol mebutate gel for actinic keratosis. N. Engl. J. Med 366, 1010\u20131019.", "ArticleIdList": ["22417254"]}, {"Citation": "Lee K-H, Xiao Z, 2012. Podophyllotoxins and analogs. In: Cragg GM, Kingston DG, Newman DJ (Eds.), Anticancer Agents from Natural Products CRC Press, Boca Raton, Florida, pp. 95\u2013122."}, {"Citation": "Lee MD, Dunne TS, Siegel MM, Chang CC, Morton GO, Borders DB, 1987a. Calichemicins, a novel family of antitumor antibiotics. 1. Chemistry and partial structure of calichemicin \u03b31I. J. Am. Chem. Soc 109, 3464\u20133466."}, {"Citation": "Lee MD, Dunne TS, Chang CC, Ellestad GA, Siegel MM, Morton GO, McGahren WJ, Borders DB, 1987b. Calichemicins, a novel family of antitumor antibiotics. 2. Chemistry and structure of calichemicin \u03b31I. J. Am. Chem. Soc 109, 3466\u20133468."}, {"Citation": "Li JW, Vederas JC, 2009. Drug discovery and natural products: end of an era or an endless frontier? Science 325, 161\u2013165.", "ArticleIdList": ["19589993"]}, {"Citation": "Li W, Yalcin M, Lin Q, Ardawi M-SM, Mousa SA, 2017. Self-assembly of green tea catechin derivatives in nanoparticles for oral lycopene delivery. J. Control. Release 248, 117\u2013124.", "ArticleIdList": ["28077264"]}, {"Citation": "Li Y, Rogoff HA, Keates S, Gao Y, Murikipudi S, Mikule K, et al., 2015. Suppression of cancer relapse and metastasis by inhibiting cancer stemness. Proc. Natl. Acad. Sci. U.S.A 112, 1839\u20131844.", "ArticleIdList": ["PMC4330785", "25605917"]}, {"Citation": "Liaw CC, Chen PC, Shih CJ, Tseng SP, Lai YM, Hsu CH, Dorrestein PC, Yang YL, 2015. Vitroprocines, new antibiotics against Acinetobacter baumannii, discovered from marine Vibrio sp. QWI-06 using mass-spectrometry-based metabolomics approach. Sci. Rep 5, 12856.", "ArticleIdList": ["PMC4523872", "26238555"]}, {"Citation": "Lima RCL, Gramsbergen SM, van Staden J, Jager AK, Kongstad KT, Staerk D, 2017. Advancing HPLC-PDA-HRMS-SPE-NMR analysis of coumarins in Coleonema album by use of orthogonal reversed-phase C18 and pentafluorophenyl separations. J. Nat. Prod 80, 1020\u20131027.", "ArticleIdList": ["28248501"]}, {"Citation": "Lin S-Y, Kawashima Y, 1987. Pluronic surfactants affecting diazepam solubility, compatibility, and adsorption from i.v. admixture solutions. PDA J. Pharm. Sci. Technol 41, 83\u201387.", "ArticleIdList": ["3612414"]}, {"Citation": "Liu C, Tadayoni BM, Bourret LA, Mattocks KM, Derr SM, Widdison WC, et al., 1996. Eradication of large colon tumor xenografts by targeted delivery of maytansinoids. Proc. Natl. Acad. Sci. U.S.A 93, 8618\u20138623.", "ArticleIdList": ["PMC38722", "8710920"]}, {"Citation": "Liu G, Bode A, Ma W-Y, Sang S, Ho C-T, Dong Z, 2001. Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line. Cancer Res 61, 5749\u20135756.", "ArticleIdList": ["11479211"]}, {"Citation": "Liu J-M, Haroun-Bouhedja F, Boisson-Vidal C, 2000. Analysis of the in vitro inhibition of mammant adenocarcinoma cell adhesion by sulphated polysaccharides. Anticancer Res 20, 3265\u20133272.", "ArticleIdList": ["11062752"]}, {"Citation": "Liu Y, Staerk D, Nielsen MN, Nyberg N, Jager AK, 2015. High-resolution hyaluronidase inhibition profiling combined with HPLC-HRMS-SPE-NMR for identification of anti-necrosis constituents in Chinese plants used to treat snakebite. Phytochemistry 119, 62\u201369.", "ArticleIdList": ["26386983"]}, {"Citation": "Lu J-M, Nurko J, Weakely SM, Jiang J, Kougias P, Lin PH, Yao Q, Chen C, 2010. Molecular mechanisms and clinical applications of norhydroguaiaretic acid (NDGA) and its derivative: an update. Med. Sci. Monit 16, RA93\u2013RA100.", "ArticleIdList": ["PMC2927326", "20424564"]}, {"Citation": "Lucas DM, Edwards RB, Lozanski G, West DA, Shin JD, Vargo MA, et al., 2009. The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo. Blood 113, 4656\u20134666.", "ArticleIdList": ["PMC2680369", "19190247"]}, {"Citation": "Lucas DM, Still PC, Bueno-Perez L, Grever MR, Kinghorn AD, 2010. Potential of plant-derived natural products in the treatment of leukemia and lymphoma. Curr. Drug Targets 11, 812\u2013822.", "ArticleIdList": ["PMC2892601", "20370646"]}, {"Citation": "Luo J, Chuang T, Chrung J, Quan J, Tsai J, Sullivan C, et al., 1998. Masoprocol (nordihydroguaiaretic acid): a new antihyperglycemic agent isolated from the creosote bush (Larrea tridentata). Eur. J. Pharmacol 346, 77\u201379.", "ArticleIdList": ["9617755"]}, {"Citation": "Mack F, Ritchie M, Sapra P, 2014. The next generation of antibody drug conjugates. Semin. Oncol 41, 637\u2013652.", "ArticleIdList": ["25440608"]}, {"Citation": "Maderna A, Leverett CA, 2015. Recent advances in the development of new auristatins: structural modifications and application in antibody drug conjugates. Mol. Pharm 12, 1798\u20131812.", "ArticleIdList": ["25697404"]}, {"Citation": "Maeda H, Matsumura Y, 1989. Tumoritropic and lymphotropic principles of macromolecular drugs. Crit. Rev. Ther. Drug Carrier Syst 6, 193\u2013210.", "ArticleIdList": ["2692843"]}, {"Citation": "Maeda H, Sawa T, Matsumura Y, Hori K, 2000. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 65, 271\u2013284.", "ArticleIdList": ["10699287"]}, {"Citation": "Mandrekar N, Thakur NL, 2009. Significance of the zebrafish model in the discovery of bioactive molecules from nature. Biotechnol. Lett 31, 171\u2013179.", "ArticleIdList": ["18931972"]}, {"Citation": "Mantaj J, Jackson PJ, Rahman KM, Thurston DE, 2017. From anthramycin to pyrrolobenzodiazepine (PBD)-containing antibody-drug conjugates (ADCs). Angew. Chem. Int. Ed. Engl 56, 462\u2013488.", "ArticleIdList": ["PMC5215561", "27862776"]}, {"Citation": "Marshall AG, Hendrickson CL, 2008. High-resolution mass spectrometers. Annu. Rev. Anal. Chem 1, 579\u2013599.", "ArticleIdList": ["20636090"]}, {"Citation": "Mazumder A, Cerella C, Diederich M, 2018. Natural scaffolds in anticancer therapy and precision medicine. Biotechnol. Adv, 10.1016/j.biotechadv.2018.04.009.", "ArticleIdList": ["10.1016/j.biotechadv.2018.04.009", "29729870"]}, {"Citation": "McCarthy JR, Weissleder R, 2008. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv. Drug Delivery Rev 60, 1241\u20131251.", "ArticleIdList": ["PMC2583936", "18508157"]}, {"Citation": "McClatchey W, 2002. From Polynesian healers to health stores: Changing perspective of Morinda citrifolia (Rubiaceae). Integr. Cancer Ther 1, 110\u2013120.", "ArticleIdList": ["14664736"]}, {"Citation": "Megoulas NC, Koupparis MA, 2005. Twenty years of evaporative light scattering detection. Crit. Rev. Anal. Chem 35, 301\u2013316."}, {"Citation": "Mi Q, Lantvit DD, Reyes-Lim E, Chai H-B, Zhao W, Lee I-S, et al., 2002. Evaluation of the potential cancer chemotherapeutic efficacy of natural product isolates employing in vivo hollow fiber tests. J. Nat. Prod 65, 842\u2013850.", "ArticleIdList": ["12088425"]}, {"Citation": "Mi Q, Pezzuto JM, Farnsworth NR, Wani MC, Kinghorn AD, Swanson SM, 2009. Use of the in vivo hollow fiber assay in natural products anticancer drug discovery. J. Nat. Prod 72, 573\u2013580.", "ArticleIdList": ["PMC2765512", "19161316"]}, {"Citation": "Mian-Ying W, West BJ, Jensen CJ, Nowicki D, Chen S, Palu AK, Anderson G, 2002. Morinda citrifloia (noni): a literature review and recent advances in noni research. Acta Pharmacol. Sin 23, 1127\u20131141.", "ArticleIdList": ["12466051"]}, {"Citation": "Miola AC, Ferreira ER, Abbade LPF, Schmitt JV, Miot HA, 2018. Randomized clinical trial testing the efficacy and safety of 0.5% colchicine cream versus photodynamic therapy with methyl aminolevulinate in the treatment of skin field cancerization: study protocol. BMC Cancer 18, 340.", "ArticleIdList": ["PMC5870300", "29587662"]}, {"Citation": "Mitsui I, Kumazawa E, Hirota Y, Aonuma M, Sugimori M, Ohsuki S, et al., 1995. A new water-soluble camptothecin derivative, DX-8951f, exhibits potent antitumor activity against human tumors in vitro and in vivo. Jpn. J. Cancer Res 86, 776\u2013782.", "ArticleIdList": ["PMC5920901", "7559102"]}, {"Citation": "Moghimi SM, Hunter AC, Murray JC, 2005. Nanomedicine: current status and future prospects. FASEB J 19, 311\u2013330.", "ArticleIdList": ["15746175"]}, {"Citation": "Mohamed A, Nguyen CH, Mamitsuka H, 2016. Current status and prospects of computational resources for natural product dereplication: a review. Brief. Bioinform 17, 309\u2013321.", "ArticleIdList": ["26153512"]}, {"Citation": "Mosmann T, 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55\u201363.", "ArticleIdList": ["6606682"]}, {"Citation": "Mu\u00f1oz-Acu\u00f1a U, Shen Q, Ren Y, Lantvit DD, Wittwer JA, Kinghorn AD, Swanson SM, Carcache de Blanco E.J., 2013. Goyazensolide induces apoptosis in cancer cells in vitro and in vivo. Int. J. Cancer Res 9, 36\u201353.", "ArticleIdList": ["PMC4303185", "25621077"]}, {"Citation": "Naik RG, Kattige SL, Bhat SV, Alreja B, de Souza NJ, Rupp RH, 1988. An antiinflammatory cum immunomodulatory piperidinylbenzopyrnose from Dysoxylum binectariferum: isolation, structure and total synthesis. Tetrahedron 44, 2081\u20132086."}, {"Citation": "Naman CB, Rattan R, Nikoulina SE, Lee J, Miller BW, Moss NA, et al., 2017. Integrating molecular networking and biological assays to target the isolation of a cytotoxic cyclic octapeptide, samoamide A, from an American Samoan marine cyanobacterium. J. Nat. Prod 80, 625\u2013633.", "ArticleIdList": ["PMC5758054", "28055219"]}, {"Citation": "Nath S, Devi GR, 2016. Three-dimensional culture systems in cancer research: focus on tumor spheroid model. Pharmacol. Ther 163, 94\u2013108.", "ArticleIdList": ["PMC4961208", "27063403"]}, {"Citation": "National Institute of Health O.D.S., 1994. \nDietary Supplement Health and Education Act (DSHEA) of 1994\nhttps://ods.od.nih.gov/About/dshea_wording.aspx. (Accessed May 25, 2018)."}, {"Citation": "Newman DJ, Cragg GM, Snader KM, 2000. The influence of natural products upon drug discovery. Nat. Prod. Rep 17, 215\u2013234.", "ArticleIdList": ["10888010"]}, {"Citation": "Newman DJ, Cragg GM, 2016. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod 79, 629\u2013661.", "ArticleIdList": ["26852623"]}, {"Citation": "Ng JS, 2011. Vinflunine: review of a new vinca alkaloid and its potential role in oncology. J. Oncol. Pharm. Pract 17, 209\u2013224.", "ArticleIdList": ["20584744"]}, {"Citation": "Nguyen DD, Wu C-H, Moree WJ, Lamsa A, Medema MH, Zhao X, et al., 2013. MS/MS networking guided analysis of molecule and gene cluster families. Proc. Natl. Acad. Sci. U.S.A 110, E2611\u2013E2620.", "ArticleIdList": ["PMC3710860", "23798442"]}, {"Citation": "Nicolaou KC, Chen JS, Dalby SM, 2009. From nature to the laboratory and into the clinic. Bioorg. Med. Chem 17, 2290\u20132303.", "ArticleIdList": ["PMC2665039", "19028103"]}, {"Citation": "Nielsen KF, Mansson M, Rank C, Frisvad JC, Larsen TO, 2011. Dereplication of microbial natural products by LC-DAD-TOFMS. J. Nat. Prod 74, 2338\u20132348.", "ArticleIdList": ["22026385"]}, {"Citation": "Norsworthy KJ, Ko CW, Lee JE, Liu J, John CS, Przepiorka D, Farrell AT, Pazdur R, 2018. FDA approval summary: Mylotarg for treatment of patients with relapsed or refractory CD33-positive acute myeloid leukemia. Oncologist 23, 1103\u20131108.", "ArticleIdList": ["PMC6192608", "29650683"]}, {"Citation": "Nothias L-F, Boutet-Mercey S, Cachet X, De La Torre E, Laboureur L, Gallard JF, et al., 2017. Environmentally friendly procedure based on supercritical fluid chromatography and tandem mass spectrometry molecular networking for the discovery of potent antiviral compounds from Euphorbia semiperfoliata. J. Nat. Prod 80, 2620\u20132629.", "ArticleIdList": ["28925702"]}, {"Citation": "Nothias L-F, Nothias-Esposito M, da Silva R, Wang M, Protsyuk I, Zhang Z, et al., 2018. Bioactivity-based molecular networking for the discovery of drug leads in natural product bioassay-guided fractionation. J. Nat. Prod 81, 758\u2013767.", "ArticleIdList": ["29498278"]}, {"Citation": "Obolskiy D, Pischel I, Siriwatanametanon N, Heinrich M, 2009. Garcinia mangostana L.: a phytochemical and pharmacological review. Phytother. Res 23, 1047\u20131065.", "ArticleIdList": ["19172667"]}, {"Citation": "Ocean AJ, Starodub AN, Bardia A, Vahdat LT, Isakoff SJ, Guarino M, et al., 2017. Sacituzumab govitecan (IMMU-132), an anti-trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: safety and pharmacokinetics. Cancer 123, 3843\u20133854.", "ArticleIdList": ["28558150"]}, {"Citation": "Ogitani Y, Hagihara K, Oitate M, Naito H, Agatsuma T, 2016a. Bystander killing effect of DS-8201a, a novel anti-human epidermal growth factor receptor 2 antibody-drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity. Cancer Sci 107, 1039\u20131046.", "ArticleIdList": ["PMC4946713", "27166974"]}, {"Citation": "Ogitani Y, Aida T, Hagihara K, Yamaguchi J, Ishii C, Harada N, et al., 2016b. DS-8201a, a novel HER2-targeting ADC with a novel DNA topoisomerase I inhibitor, demonstrates a promising antitumor efficacy with differentiation from T-DM1. Clin. Cancer Res 22, 5097\u20135108.", "ArticleIdList": ["27026201"]}, {"Citation": "Okutan L, Kongstad KT, Jager AK, Staerk D, 2014. High-resolution \u03b1-amylase assay combined with high-performance liquid chromatography-solid-phase extraction-nuclear magnetic resonance spectroscopy for expedited identification of \u03b1-amylase inhibitors: proof of concept and \u03b1-amylase inhibitor in cinnamon. J. Agric. Food Chem 62, 11465\u201311471.", "ArticleIdList": ["25368916"]}, {"Citation": "Olivon F, Allard P-M, Koval A, Righi D, Genta-Jouve G, Neyts J, et al., 2017a. Bioactive natural products prioritization using massive multi-informational molecular networks. ACS Chem. Biol 12, 2644\u20132651.", "ArticleIdList": ["28829118"]}, {"Citation": "Olivon F, Grelier G, Roussi F, Litaudon M, Touboul D, 2017b. MZmine 2 data-preprocessing to enhance molecular networking reliability. Anal. Chem 89, 7836\u20137840.", "ArticleIdList": ["28644610"]}, {"Citation": "Olivon F, Roussi F, Litaudon M, Touboul D, 2017c. Optimized experimental workflow for tandem mass spectrometry molecular networking in metabolomics. Anal. Bioanal. Chem 409, 5767\u20135778.", "ArticleIdList": ["28762069"]}, {"Citation": "Ortholand JY, Ganesan A, 2004. Natural products and combinatorial chemistry: back to the future. Curr. Opin. Chem. Biol 8, 271\u2013280.", "ArticleIdList": ["15183325"]}, {"Citation": "Ovalle-Magallanes B, Eugenio-Perez D, Pedraza-Chaverri J, 2017. Medicinal properties of mangosteen (Garcinia mangostana L.): a comprehensive update. Food Chem. Toxicol 109, 102\u2013122.", "ArticleIdList": ["28842267"]}, {"Citation": "Pan L, Carcache de Blanco E.J., Kinghorn AD, 2009. Plant-derived natural products as leads for drug discovery. In: Osbourn AE, Lanzotti V (Eds.), Plant-derived Natural Products: Synthesis, Function, and Application Springer, New York, pp. 547\u2013567."}, {"Citation": "Pan L, Kardono LBS, Riswan S, Chai H-B, Carcache de Blanco E.J., Pannell CM, et al., 2010. Isolation and characterization of minor analogues of silvestrol and other constituents from a large-scale re-collection of Aglaia foveolata. J. Nat. Prod 73, 1873\u20131878.", "ArticleIdList": ["PMC2993763", "20939540"]}, {"Citation": "Pan L, Woodard JL, Lucas DM, Fuchs JR, Kinghorn AD, 2014. Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species. Nat. Prod. Rep 31, 924\u2013939.", "ArticleIdList": ["PMC4091845", "24788392"]}, {"Citation": "Pantziarka P, Bouche G, Meheus L, Sukhatme V, Sukhatme VP, Vikas P, 2014. The repurposing drugs in oncology (ReDO) project. Ecancermedicalscience 8, 442.", "ArticleIdList": ["PMC4096030", "25075216"]}, {"Citation": "Park JW, Benz CC, Martin FJ, 2004. Future directions of liposome- and immunoliposome-based cancer therapeutics. Semin. Oncol 31, 196\u2013205.", "ArticleIdList": ["15717745"]}, {"Citation": "Pawlus AD, Su B-N, Keller WJ, Kinghorn AD, 2005. An anthraquinone with potent quinone reductase-inducing activity and other constituent of the fruits of Morinda citrifolia (noni). J. Nat. Prod 68, 1720\u20131722.", "ArticleIdList": ["16378361"]}, {"Citation": "Pedraza-Chaverri J, Cardenas-Rodriguez N, Orozco-Ibarra M, Perez-Rojas JM, 2008. Medicinal properties of mangosteen (Garcinia mangostana). Food Chem. Toxicol 46, 3227\u20133239.", "ArticleIdList": ["18725264"]}, {"Citation": "Pelaz B, Alexiou C, Alvarez-Puebla RA, Alves F, Andrews AM, Ashraf S, et al., 2017. Diverse applications of nanomedicine. ACS Nano 11, 2313\u20132381.", "ArticleIdList": ["PMC5371978", "28290206"]}, {"Citation": "Perez-Victoria I, Martin J, Reyes F, 2016. Combined LC/UV/MS and NMR strategies for the dereplication of marine natural products. Planta Med 82, 857\u2013871.", "ArticleIdList": ["27002401"]}, {"Citation": "Peters C, Brown S, 2015. Antibody-drug conjugates as novel anti-cancer chemotherapeutics. Biosci. Rep 35, e00225.", "ArticleIdList": ["PMC4613712", "26182432"]}, {"Citation": "Pettit GR, Kamano Y, Herald CL, Tuinman AA, Boettner FE, Kizu H, et al., 1987. The isolation and structure of a remarkable marine animal antineoplastic constituent: dolastatin 10. J. Am. Chem. Soc 109, 6883\u20136885."}, {"Citation": "Pillow T, Polson AG, Zheng B Silvestrol antibody-drug conjugates and methods of use. U.S. Pat. Publ 20170348422A1, 2017."}, {"Citation": "Polachi N, Bai G, Li T, Chu Y, Wang X, Li S, et al., 2016. Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer - a comprehensive review. Eur. J. Med. Chem 123, 577\u2013595.", "ArticleIdList": ["27517806"]}, {"Citation": "Pope-Harman A, Cheng MM-C, Robertson F, Sakamoto J, Ferrari M, 2007. Biomedical nanotechnology for cancer. Med. Clin. North Am 91, 899\u2013927.", "ArticleIdList": ["17826110"]}, {"Citation": "Portney NG, Ozkan M, 2006. Nano-oncology: drug delivery, imaging, and sensing. Anal. Bioanal. Chem 384, 620\u2013630.", "ArticleIdList": ["16440195"]}, {"Citation": "Potterat O, Hamburger M, 2007. Morinda citrifolia (noni) fruit - phytochemistry, pharmacology, safety. Planta Med 73, 191\u2013199.", "ArticleIdList": ["17286240"]}, {"Citation": "Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM, 2006. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol. Sci 90, 296\u2013303.", "ArticleIdList": ["16407094"]}, {"Citation": "Priyadarsini RV, Nagini S, 2012. Cancer chemoprevention by dietary phytochemicals: promises and pitfalls. Curr. Pharm. Biotechnol 13, 125\u2013136.", "ArticleIdList": ["21466433"]}, {"Citation": "Prompruk K, Govender T, Zhang S, Xiong CD, Stolnik S, 2005. Synthesis of a novel PEG-block-poly(aspartic acid-stat-phenylalanine) copolymer shows potential for formation of a micellar drug carrier. Int. J. Pharm 297, 242\u2013253.", "ArticleIdList": ["15907607"]}, {"Citation": "Pye CR, Bertin MJ, Lokey RS, Gerwick WH, Linington RG, 2017. Retrospective analysis of natural products provides insights for future discovery trends. Proc. Natl. Acad. Sci. U.S.A 114, 5601\u20135606.", "ArticleIdList": ["PMC5465889", "28461474"]}, {"Citation": "Quinn RA, Nothias L-F, Vining O, Meehan M, Esquenazi E, Dorrestein PC, 2017. Molecular networking as a drug discovery, drug metabolism, and precision medicine strategy. Trends Pharmacol. Sci 38, 143\u2013154.", "ArticleIdList": ["27842887"]}, {"Citation": "Rahier NJ, Thomas CJ, Hecht SM, 2012. Camptothecin and its analogs. In: Cragg GM, Kingston DG, Newman DJ (Eds.), Anticancer Agents form Natural Products CRC Press, Boca Raton, Florida, pp. 5\u201326."}, {"Citation": "Ramage CM, Sando L, Peace CP, Carroll BJ, Drew RA, 2004. Genetic diversity revealed in the apomictic fruit species Garcinia mangostana L. (mangosteen). Euphytica 136, 1\u201310."}, {"Citation": "Rao MM, Kingston DGI, 1982. Plant anticancer agents XII. Isolation and structure elucidation of new cytotoxic quinones from Tabebuia cassinoides. J. Nat. Prod 45, 600\u2013604.", "ArticleIdList": ["7153777"]}, {"Citation": "Rautio J, Meanwell NA, Di L, Hageman MJ, 2018. The expanding role of prodrugs in contemporary drug design and development. Nat. Rev. Drug Discov. Article in press DOI: 10.1038/nrd.2018.46.", "ArticleIdList": ["10.1038/nrd.2018.46", "29700501"]}, {"Citation": "Reichert JM, Valge-Archer VE, 2007. Development trends for monoclonal antibody cancer therapeutics. Nat. Rev. Drug Discov 6, 349\u2013356.", "ArticleIdList": ["17431406"]}, {"Citation": "Remy S, Olivon F, Desrat S, Blanchard F, Eparvier V, Leyssen P, et al., 2018. Structurally diverse diterpenoids from Sandwithia guyanensis. J. Nat. Prod 81, 901\u2013912.", "ArticleIdList": ["29493237"]}, {"Citation": "Ren Y, Acu\u00f1a UM, Jim\u00e9nez F, Garc\u00eda R, Mej\u00eda M, Chai H, et al., 2012. Cytotoxic and NF-\u03baB inhibitory sesquiterpene lactones from Piptocoma rufescens. Tetrahedron 68, 2671\u20132678.", "ArticleIdList": ["PMC3369275", "22685350"]}, {"Citation": "Rida PC, LiVecche D, Ogden A, Zhou J, Aneja R, 2015. The noscapine chronicle: a pharmaco-historic biography of the opiate alkaloid family and its clinical applications. Med. Res. Rev 35, 1072\u20131096.", "ArticleIdList": ["PMC4778555", "26179481"]}, {"Citation": "Riedl A, Schlederer M, Pudelko K, Stadler M, Walter S, Unterleuthner D, et al., 2017. Comparison of cancer cells in 2D vs. 3D culture reveals differences in AKT\u2013mTOR\u2013S6K signaling and drug responses. J. Cell Sci 130, 203\u2013218.", "ArticleIdList": ["27663511"]}, {"Citation": "Roy A, Jauhari N, Bharadvaja N, 2018. Medicinal plants as a potential source of chemopreventive agents. In: Akhtar MS, Swamy MK (Eds.), Anticancer Plants: Natural Products and Biotechnological Implements Springer Nature, Singapore, pp. 109\u2013140."}, {"Citation": "Rubinstein AL, 2006. Zebrafish assays for drug toxicity screening. Expert Opin. Drug Metab. Toxicol 2, 231\u2013240.", "ArticleIdList": ["16866609"]}, {"Citation": "Sahoo SK, Ma W, Labhasetwar V, 2004. Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer. Int. J. Cancer 112, 335\u2013340.", "ArticleIdList": ["15352049"]}, {"Citation": "Santra S, Liesenfeld B, Dutta D, Chatel D, Batich CD, Tan W, Moudgil BM, Mericle RA, 2005. Folate conjugated fluorescent silica nanoparticles for labeling neoplastic cells. J. Nanosci. Nanotechnol 5, 899\u2013904.", "ArticleIdList": ["16060150"]}, {"Citation": "Sarker SD, Nahar L, 2012. Hyphenated techniques and their applications in natural products analysis. In: Sarker SD, Nahar L (Eds.), Natural Products Isolation Humana Press, Totowa, NJ, pp. 301\u2013340.", "ArticleIdList": ["22367902"]}, {"Citation": "Sawant RR, Torchilin VP, 2010. Polymeric micelles: polyethylene glycol-phosphatidylethanolamine (PEG-PE)-based micelles as an example. In: Grobmyer SR, Moudgil BM (Eds.), Cancer Nanotechnology, Methods and Protocols Humana Press, New York, pp. 131\u2013150.", "ArticleIdList": ["20217593"]}, {"Citation": "Schorn M, Zettler J, Noel JP, Dorrestein PC, Moore BS, Kaysser L, 2014. Genetic basis for the biosynthesis of the pharmaceutically important class of epoxyketone proteasome inhibitors. ACS Chem. Biol 9, 301\u2013309.", "ArticleIdList": ["PMC4041076", "24168704"]}, {"Citation": "Scolamiero G, Pazzini C, Bonafe F, Guarnieri C, Muscari C, 2018. Effects of \u03b1-mangostin on viability, growth and cohesion of multicellular spheroids derived from human breast cancer cell lines. Int. J. Med. Sci 15, 23\u201330.", "ArticleIdList": ["PMC5765736", "29333084"]}, {"Citation": "Seger C, Sturm S, Stuppner H, 2013. Mass spectrometry and NMR spectroscopy: modern high-end detectors for high resolution separation techniques - state of the art in natural product HPLC-MS, HPLC-NMR, and CE-MS hyphenations. Nat. Prod. Rep 30, 970\u2013987.", "ArticleIdList": ["23739842"]}, {"Citation": "Sengupta S, Eavarone D, Capila I, Zhao G, Watson N, Kiziltepe T, Sasisekharan R, 2005. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature 436, 568\u2013572.", "ArticleIdList": ["16049491"]}, {"Citation": "Senter PD, Sievers EL, 2012. The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma. Nat. Biotechnol 30, 631\u2013637.", "ArticleIdList": ["22781692"]}, {"Citation": "Seo E-K, Kim N-C, Mi Q, Chai H, Wall ME, Wani MC, et al., 2001. Macharistol, a new cytotoxic cinnamylphenol from the stems of Machaerium aristulatum. J. Nat. Prod 64, 1483\u20131485.", "ArticleIdList": ["11720542"]}, {"Citation": "Sharkey RM, McBride WJ, Cardillo TM, Govindan SV, Wang Y, Rossi EA, Chang CH, Goldenberg DM, 2015. Enhanced delivery of SN-38 to human tumor xenografts with an anti-trop-2-SN-38 antibody conjugate (sacituzumab govitecan). Clin. Cancer Res 21, 5131\u20135138.", "ArticleIdList": ["26106073"]}, {"Citation": "Sharkey RM, Govindan SV, Cardillo TM, Donnell J, Xia J, Rossi EA, Chang CH, Goldenberg DM, 2018. Selective and concentrated accretion of SN-38 with a CEACAM5-targeting antibody-drug conjugate (ADC), labetuzumab govitecan (IMMU-130). Mol. Cancer Ther 17, 196\u2013203.", "ArticleIdList": ["29079710"]}, {"Citation": "Shi S-Y, Zhang Y-P, Jiang X-Y, Chen X-Q, Huang K-L, Zhou H-H, Jiang X-Y, 2009. Coupling HPLC to on-line, post-column (bio)chemical assays for high-resolution screening of bioactive compounds from complex mixtures. Trends Anal. Chem 28, 865\u2013877."}, {"Citation": "Shi Y, Pan C, Wang K, Chen X, Wu X, Chen CA, Wu B, 2017. Synthetic multispecies microbial communities reveals shifts in secondary metabolism and facilitates cryptic natural product discovery. Environ. Microbiol 19, 3606\u20133618.", "ArticleIdList": ["28714207"]}, {"Citation": "Shibata M-A, Matoba Y, Tosa H, Iinuma M, 2013. Effects of mangosteen pericarp extracts against mammary cancer. Alt. Int. Med 2, 139."}, {"Citation": "Siegel RL, Miller KD, Jemal A, 2018. Cancer statistics, 2018. CA Cancer J. Clin 68, 7\u201330.", "ArticleIdList": ["29313949"]}, {"Citation": "Sievers EL, Senter PD, 2013. Antibody-drug conjugates in cancer therapy. Annu. Rev. Med 64, 15\u201329.", "ArticleIdList": ["23043493"]}, {"Citation": "Singh S, Sharma B, Kanwar SS, Kumar A, 2016. Lead phytochemicals for anticancer drug development. Front. Plant Sci 7, 1667.", "ArticleIdList": ["PMC5099879", "27877185"]}, {"Citation": "Singh SK, Lillard JW, Singh R, 2018. Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer. Cancer Lett 427, 49\u201362.", "ArticleIdList": ["PMC5953846", "29678549"]}, {"Citation": "Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, et al., 2001. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N. Engl. J. Med 344, 783\u2013792.", "ArticleIdList": ["11248153"]}, {"Citation": "Sleire L, Forde HE, Netland IA, Leiss L, Skeie BS, Enger PO, 2017. Drug repurposing in cancer. Pharmacol. Res 124, 74\u201391.", "ArticleIdList": ["28712971"]}, {"Citation": "Smith AL, Nicolaou KC, 1996. The enediyne antibiotics. J. Med. Chem 39, 2103\u20132117.", "ArticleIdList": ["8667354"]}, {"Citation": "Smith BR, Cheng Z, De A, Koh AL, Sinclair R, Gambhir SS, 2008. Real-time intravital imaging of RGD-quantum dot binding to luminal endothelium in mouse tumor neovasculature. Nano Lett 8, 2599\u20132606.", "ArticleIdList": ["PMC4161135", "18386933"]}, {"Citation": "Smith T, Kawa K, Eckl V, Morton C, Stredney R, 2017. Herbal supplement sales in U.S. increase 7.7% in 2016. Consumer preferences shifting toward ingredients with general wellness benefits, driving growth of adaptogens and digestive health products. Herbalgram 115, 56\u201365."}, {"Citation": "Smolewski P, 2008. Terameprocol, a novel site-specific transription inhibitor with anticancer activity. IDrugs 11, 204\u2013214.", "ArticleIdList": ["18311658"]}, {"Citation": "Sonbol MB, Bekaii-Saab T, 2018. A clinical trial protocol paper discussing the BRIGHTER study. Future Oncol 14, 901\u2013906.", "ArticleIdList": ["29297698"]}, {"Citation": "Spectrum Pharmaceuticals Inc., 2017. \nMarqibo (vincristine sulpfate liposome injection)\nhttp://www.marqibo.com/. (Accessed May 30, 2018)."}, {"Citation": "Sporn MB, Liby KT, 2005. Cancer chemoprevention: scientific promise, clinical uncertainty. Nat. Clin. Pract. Oncol 2, 518\u2013525.", "ArticleIdList": ["16205771"]}, {"Citation": "Staerk D, Kesting JR, Sairafianpour M, Witt M, Asili J, Emami SA, Jaroszewski JW, 2009. Accelerated dereplication of crude extracts using HPLC-PDA-MS-SPE-NMR: quinolinone alkaloids of Haplophyllum acutifolium. Phytochemistry 70, 1055\u20131061.", "ArticleIdList": ["19540540"]}, {"Citation": "Starodub AN, Ocean AJ, Shah MA, Guarino MJ, Picozzi VJ Jr., Vahdat LT, et al., 2015. First-in-human trial of a novel anti-trop-2 antibody-SN-38 conjugate, sacituzumab govitecan, for the treatment of diverse metastatic solid tumors. Clin. Cancer Res 21, 3870\u20133878.", "ArticleIdList": ["PMC4558321", "25944802"]}, {"Citation": "Stock K, Estrada MF, Vidic S, Gjerde K, Rudisch A, Santo VE, et al., 2016. Capturing tumor complexity in vitro: comparative analysis of 2D and 3D tumor models for drug discovery. Sci. Rep 6, 28951.", "ArticleIdList": ["PMC4929472", "27364600"]}, {"Citation": "Su BN, Pawlus AD, Jung HA, Keller WJ, McLaughlin JL, Kinghorn AD, 2005. Chemical constituents of the fruits of Morinda citrifolia (noni) and their antioxidant activity. J. Nat. Prod 68, 592\u2013595.", "ArticleIdList": ["15844957"]}, {"Citation": "Suffness M, Douros JD, 1981. Discovery of antitumor agents from natural sources. Trends Pharmacol. Sci 2, 307\u2013310."}, {"Citation": "Takegawa N, Nonagase Y, Yonesaka K, Sakai K, Maenishi O, Ogitani Y, et al., 2017. DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance. Int. J. Cancer 141, 1682\u20131689.", "ArticleIdList": ["28677116"]}, {"Citation": "Teicher BA, Chari RV, 2011. Antibody conjugate therapeutics: challenges and potential. Clin. Cancer Res 17, 6389\u20136397.", "ArticleIdList": ["22003066"]}, {"Citation": "Thomas I, Gregg B, 2017. Metformin; a review of its history and future: from lilac to longevity. Pediatr. Diabetes 18, 10\u201316.", "ArticleIdList": ["28052534"]}, {"Citation": "Tsuchikama K, An Z, 2018. Antibody-drug conjugates: recent advances in conjugation and linker chemistries. Protein Cell 9, 33\u201346.", "ArticleIdList": ["PMC5777969", "27743348"]}, {"Citation": "U.S. Food & Drug Administration, 2015. \nFDA approved drug products\nhttps://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207793. (Accessed July 7, 2018)."}, {"Citation": "U.S. Food & Drug Administration, 2016. FDA grants orphan drug status for napabucasin. Oncology Times 38, 25."}, {"Citation": "U.S. Food & Drug Administration, 2017. \nFDA approves inotuzumab ozogamicin for relapsed or refractory B-cell precursor ALL\nhttps://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm572133.htm. (Accessed June 6, 2018)."}, {"Citation": "U.S. National Library of Medicine, 2018a. \n63 studies found for flavopiridol\nhttps://www.clinicaltrials.gov/ct2/results?cond=&term=flavopiridol&cntry=&state=&city=&dist=. (Accessed June 10, 2018)."}, {"Citation": "U.S. National Library of Medicine, 2018b. \n75 studies found for podophyllotoxin\nhttps://clinicaltrials.gov/ct2/results?cond=&term=podophyllotoxin&cntry=&state=&city=&dist=&Search=Search&recrs=a&recrs=b&recrs=d&recrs=e. (Accessed June 10, 2018)."}, {"Citation": "U.S. National Library of Medicine, 2018c. \nA study of DSP-0337 in patients with advanced solid tumors to determine the safety and the pharmacokinetic profile\nhttps://clinicaltrials.gov/ct2/show/NCT03416816?term=DSP-0337&rank=1. (Accessed June 25, 2018)."}, {"Citation": "Vallet M, Vanbellingen QP, Fu T, Le Caer J-P, Della-Negra S, Touboul D, et al., 2017. An integrative approach to decipher the chemical antagonism between the competing endophytes Paraconiothyrium variabile and Bacillus subtilis. J. Nat. Prod 80, 2863\u20132873.", "ArticleIdList": ["29139291"]}, {"Citation": "van Middlesworth F, Cannell RJP, 1998. Dereplication and partial identification of natural products. In: Cannell RJP (Ed.) Natural Products Isolation Humana Press, Totowa, NJ, pp. 279\u2013327."}, {"Citation": "Verma S, Miles D, Gianni L, Krop IE, Welslau M, Baselga J, et al., 2012. Trastuzumab emtansine for HER2-positive advanced breast cancer. N. Engl. J. Med 367, 1783\u20131791.", "ArticleIdList": ["PMC5125250", "23020162"]}, {"Citation": "von Hagens C, Walter-Sack I, Goeckenjan M, Osburg J, Storch-Hagenlocher B, Sertel S, et al., 2017. Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2). Breast Cancer Res. Treat 164, 359\u2013369.", "ArticleIdList": ["28439738"]}, {"Citation": "Wang H, Khor TO, Shu L, Su Z-Y, Fuentes F, Lee J-H, Kong A-NT, 2012. Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability. Anticancer Agents Med. Chem 12, 1281\u20131305.", "ArticleIdList": ["PMC4017674", "22583408"]}, {"Citation": "Wang M-H, Zhang K-J, Gu Q-L, Bi X-L, Wang J-X, 2017. Pharmacology of mangostins and their derivatives: a comprehensive review. Chin. J. Nat. Med 15, 81\u201393.", "ArticleIdList": ["28284429"]}, {"Citation": "Wang M, Carver JJ, Phelan VV, Sanchez LM, Garg N, Peng Y, et al., 2016. Sharing and community curation of mass spectrometry data with global natural products social molecular networking. Nat. Biotechnol 34, 828\u2013837.", "ArticleIdList": ["PMC5321674", "27504778"]}, {"Citation": "Watrous J, Roach P, Alexandrov T, Heath BS, Yang JY, Kersten RD, et al., 2012. Mass spectral molecular networking of living microbial colonies. Proc. Natl. Acad. Sci. U.S.A 109, E1743\u2013E1752.", "ArticleIdList": ["PMC3387089", "22586093"]}, {"Citation": "Widdison WC, Wilhelm SD, Cavanagh EE, Whiteman KR, Leece BA, Kovtun Y, et al., 2006. Semisynthetic maytansine analogues for the targeted treatment of cancer. J. Med. Chem 49, 4392\u20134408.", "ArticleIdList": ["16821799"]}, {"Citation": "Wiernik PH, 2016. Alvocidib (flavopiridol) for the treatment of chronic lymphocytic leukemia. Expert Opin. Investig. Drugs 25, 729\u2013734.", "ArticleIdList": ["26998706"]}, {"Citation": "Wilczewska AZ, Niemirowicz K, Markiewicz KH, Car H, 2012. Nanoparticles as drug delivery systems. Pharmacol. Rep 64, 1020\u20131037.", "ArticleIdList": ["23238461"]}, {"Citation": "Wilson ID, Brinkman UAT, 2007. Hype and hypernation: multiple hyphenation of column liquid chromatography and spectroscopy. Trends Anal. Chem 26, 847\u2013854."}, {"Citation": "Winer ES, DeAngelo DJ, 2018. A review of omacetaxine: a chronic myeloid leukemia treatment resurrected. Oncol. Ther 6, 9\u201320.", "ArticleIdList": ["PMC7359993", "32700137"]}, {"Citation": "Wolfender J-L, Queiroz EF, Hostettmann K, 2006. The importance of hyphenated techniques in the discovery of new lead compounds from nature. Expert Opin. Drug Discov 1, 237\u2013260.", "ArticleIdList": ["23495845"]}, {"Citation": "Wolfender J-L, Marti G, Thomas A, Bertrand S, 2015. Current approaches and challenges for the metabolite profiling of complex natural extracts. J. Chromatogr. A 1382, 136\u2013164.", "ArticleIdList": ["25464997"]}, {"Citation": "Wu C, Medema MH, Lakamp RM, Zhang L, Dorrestein PC, Choi YH, van Wezel GP, 2016. Leucanicidin and endophenasides result from methyl-rhamnosylation by the same tailoring enzymes in Kitasatospora sp. MBT66. ACS Chem. Biol 11, 478\u2013490.", "ArticleIdList": ["26675041"]}, {"Citation": "Wubshet SG, Nyberg NT, Tejesvi MV, Pirttila AM, Kajula M, Mattila S, Staerk D, 2013. Targeting high-performance liquid chromatography-high-resolution mass spectrometry-solid-phase extraction-nuclear magnetic resonance analysis with high-resolution radical scavenging profiles - bioactive secondary metabolites from the endophytic fungus Penicillium namyslowskii. J. Chromatogr. A 1302, 34\u201339.", "ArticleIdList": ["23827469"]}, {"Citation": "Wubshet SG, Brighente IM, Moaddel R, Staerk D, 2015. Magnetic ligand fishing as a targeting tool for HPLC-HRMS-SPE-NMR: \u03b1-glucosidase inhibitory ligands and alkylresorcinol glycosides from Eugenia catharinae. J. Nat. Prod 78, 2657\u20132665.", "ArticleIdList": ["PMC5036580", "26496505"]}, {"Citation": "Wubshet SG, Tahtah Y, Heskes AM, Kongstad KT, Pateraki I, Hamberger B, Moller BL, Staerk D, 2016. Identification of PTP1B and \u03b1-glucosidase inhibitory serrulatanes from Eremophila spp. by combined use of dual high-resolution PTP1B and \u03b1-glucosidase inhibition profiling and HPLC-HRMS-SPE-NMR. J. Nat. Prod 79, 1063\u20131072.", "ArticleIdList": ["26960032"]}, {"Citation": "Wurth R, Thellung S, Bajetto A, Mazzanti M, Florio T, Barbieri F, 2016. Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds. Drug Discov Today 21, 190\u2013199.", "ArticleIdList": ["26456577"]}, {"Citation": "Xu WK, Jiang H, Yang K, Wang YQ, Zhang Q, Zuo J, 2017. Development and in vivo evaluation of self-microemulsion as delivery system for \u03b1-mangostin. Kaohsiung J. Med. Sci 33, 116\u2013123.", "ArticleIdList": ["28254113"]}, {"Citation": "Yang JY, Sanchez LM, Rath CM, Liu X, Boudreau PD, Bruns N, et al., 2013. Molecular networking as a dereplication strategy. J. Nat. Prod 76, 1686\u20131699.", "ArticleIdList": ["PMC3936340", "24025162"]}, {"Citation": "Yip D, Cho CH, 2013. A multicellular 3D heterospheroid model of liver tumor and stromal cells in collagen gel for anti-cancer drug testing. Biochem. Biophys. Res. Commun 433, 327\u2013332.", "ArticleIdList": ["23501105"]}, {"Citation": "Yokoyama M, Miyauchi M, Yamada N, Okano T, Sakurai Y, Kataoka K, Inoue S, 1990. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res 50, 1693\u20131700.", "ArticleIdList": ["2306723"]}, {"Citation": "Young C, Schluep T, Hwang J, Eliasof S, 2011. CRLX101 (formerly IT-101)-A novel nanopharmaceutical of camptothecin in clinical development. Curr. Bioact. Compd 7, 8\u201314.", "ArticleIdList": ["PMC3182091", "22081768"]}, {"Citation": "Yu T-W, Floss HG, Cragg GM, Newman DJ, 2012. Ansamitocins (maytansinoids). In: Cragg GM, Kingston DG, Newman DJ (Eds.), Anticancer Agents from Natural Products CRC Press, Boca Raton, Florida, pp. 407\u2013428."}, {"Citation": "Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK, 1995. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55, 3752\u20133756.", "ArticleIdList": ["7641188"]}, {"Citation": "Zein N, Sinha AM, McGahren WJ, Ellestad GA, 1988. Calicheamicin \u03b31I: an antitumor antibiotic that cleaves double-stranded DNA site specifically. Science 240, 1198\u20131201.", "ArticleIdList": ["3240341"]}, {"Citation": "Zhang C, Yu G, Shen Y, 2017. The naturally occurring xanthone \u03b1-mangostin induces ROS-mediated cytotoxicity in non-small scale lung cancer cells. Saudi J. Biol. Sci 25, 1090\u20131095.", "ArticleIdList": ["PMC6116860", "30174507"]}, {"Citation": "Zhang Y, Jin Z, Zhou H, Ou X, Xu Y, Li H, Liu C, Li B, 2016. Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin. Cancer Med 5, 1251\u20131258.", "ArticleIdList": ["PMC4924383", "26899963"]}, {"Citation": "Zhao M, Liu M, 2018. New avenues for nanoparticle-related therapies. Nanoscale Res Lett 13, 136.", "ArticleIdList": ["PMC5940972", "29740711"]}]}], "History": [{"Year": "2018", "Month": "7", "Day": "31"}, {"Year": "2019", "Month": "1", "Day": "3"}, {"Year": "2019", "Month": "1", "Day": "7"}, {"Year": "2019", "Month": "1", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "2", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "8"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30633954", "NIHMS1009518", "PMC6614024", "10.1016/j.biotechadv.2019.01.004", "S0734-9750(19)30004-7"]}}]}